Division of Pediatric Critical Care, Department of Pediatrics, Children's Foundation Research Institute at Le Bonheur Children's Hospital, University of Tennessee Health Sciences , Memphis, Tennessee.
Department of Physiology, University of Kentucky , Lexington, Kentucky.
Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L418-L427. doi: 10.1152/ajplung.00199.2018. Epub 2019 Jan 10.
We previously showed that mice deficient in apoptosis signal-regulating kinase-1 (ASK1) were partially protected against ventilator-induced lung injury. Because ASK1 can promote both cell death and inflammation, we hypothesized that ASK1 activation regulates inflammasome-mediated inflammation. Mice deficient in ASK1 expression (ASK1) exhibited significantly less inflammation and lung injury (as measured by neutrophil infiltration, IL-6, and IL-1β) in response to treatment with inhaled lipopolysaccharide (LPS) compared with wild-type (WT) mice. To determine whether this proinflammatory response was mediated by ASK1, we investigated inflammasome-mediated responses to LPS in primary macrophages and bone marrow-derived macrophages (BMDMs) from WT and ASK1 mice, as well as the mouse alveolar macrophage cell line MH-S. Cells were treated with LPS alone for priming or LPS followed by ATP for activation. When macrophages were stimulated with LPS followed by ATP to activate the inflammasome, we found a significant increase in secreted IL-1β from WT cells compared with ASK1-deficient cells. LPS priming stimulated an increase in NOD-like receptor 3 (NLRP3) and pro-IL-1β in WT BMDMs, but expression of NLRP3 was significantly decreased in ASK1 BMDMs. Subsequent ATP treatment stimulated an increase in cleaved caspase-1 and IL-1β in WT BMDMs compared with ASK1 BMDMs. Similarly, treatment of MH-S cells with LPS + ATP caused an increase in both cleaved caspase-1 and IL-1β that was diminished by the ASK-1 inhibitor NQDI1. These results demonstrate, for the first time, that ASK1 promotes inflammasome priming.
我们之前的研究表明,凋亡信号调节激酶-1(ASK1)缺失的小鼠对内毒素诱导的肺损伤具有部分保护作用。由于 ASK1 可以促进细胞死亡和炎症,我们假设 ASK1 的激活调节炎症小体介导致炎。与野生型(WT)小鼠相比,ASK1 表达缺失(ASK1)的小鼠在吸入脂多糖(LPS)后炎症和肺损伤(通过中性粒细胞浸润、IL-6 和 IL-1β 测量)明显减少。为了确定这种促炎反应是否由 ASK1 介导,我们研究了 LPS 在 WT 和 ASK1 小鼠原代巨噬细胞和骨髓来源的巨噬细胞(BMDMs)以及肺泡巨噬细胞系 MH-S 中的炎症小体介导的反应。细胞用 LPS 单独处理进行初始激活或 LPS 后用 ATP 进行激活。当巨噬细胞用 LPS 后用 ATP 激活炎症小体时,我们发现 WT 细胞分泌的 IL-1β 与 ASK1 缺陷细胞相比显著增加。LPS 初始激活刺激 WT BMDM 中 NOD 样受体 3(NLRP3)和前 IL-1β 的增加,但 ASK1 BMDM 中 NLRP3 的表达明显减少。随后的 ATP 处理刺激 WT BMDM 中 cleaved caspase-1 和 IL-1β 的增加,而 ASK1 BMDM 中则减少。类似地,用 LPS + ATP 处理 MH-S 细胞会导致 cleaved caspase-1 和 IL-1β 的增加,而 ASK-1 抑制剂 NQDI1 则减弱了这种增加。这些结果首次表明,ASK1 促进炎症小体的初始激活。